Cefoxitin: a hospital study.
- 30 April 1977
- Vol. 1 (6069) , 1126-1128
- https://doi.org/10.1136/bmj.1.6069.1126
Abstract
Cefoxitin is a new cephamycin antibiotic that has recently become available for clinical trial. We report here the results of an uncontrolled trial of cefoxitin treatment in 31 hospital patients with various acute infections, 20 of whom were cured. Serum, urine, and bile concentrations of cefoxitin greatly exceeded the minimum inhibitory concentration (MIC) required for clinically important Gram-negative organisms. We conclude that cefoxitin will have a place in the management of serious infections, particularly in the abdominal cavity and renal tracts.Keywords
This publication has 8 references indexed in Scilit:
- Cefuroxime, a New Cephalosporin Antibiotic: Activity In VitroAntimicrobial Agents and Chemotherapy, 1976
- Comparative Study of the In Vitro Antibacterial Activity of Cefoxitin, Cefuroxime, and CephaloridineAntimicrobial Agents and Chemotherapy, 1976
- Cephamycins: A review, prospects and some original observationsInfection, 1975
- Susceptibility of Clinical Isolates of Bacteria to Cefoxitin and CephalothinAntimicrobial Agents and Chemotherapy, 1974
- Cefoxitin, a Semisynthetic Cephamycin Antibiotic: Antibacterial Spectrum and Resistance to Hydrolysis by Gram-Negative Beta-LactamasesAntimicrobial Agents and Chemotherapy, 1974
- Cefoxitin, a Semisynthetic Cephamycin Antibiotic: In Vivo EvaluationAntimicrobial Agents and Chemotherapy, 1974
- Cefoxitin, a New Semi-synthetic Cephamycin: An In-vitro and In-vivo Comparison with CephalothinBMJ, 1973
- Semisynthetic cephalosporins via a novel acyl exchange reactionJournal of the American Chemical Society, 1972